Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Aug;75(16):7769-73.
doi: 10.1128/JVI.75.16.7769-7773.2001.

Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells

W D Crill  1 , J T Roehrig
Affiliations

Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells

W D Crill et al. J Virol. 2001 Aug.

Abstract

The specific mechanisms by which antibodies neutralize flavivirus infectivity are not completely understood. To study these mechanisms in more detail, we analyzed the ability of a well-defined set of anti-dengue (DEN) virus E-glycoprotein-specific monoclonal antibodies (MAbs) to block virus adsorption to Vero cells. In contrast to previous studies, the binding sites of these MAbs were localized to one of three structural domains (I, II, and III) in the E glycoprotein. The results indicate that most MAbs that neutralize virus infectivity do so, at least in part, by the blocking of virus adsorption. However, MAbs specific for domain III were the strongest blockers of virus adsorption. These results extend our understanding of the structure-function relationships in the E glycoprotein of DEN virus and provide the first direct evidence that domain III encodes the primary flavivirus receptor-binding motif.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Representative dose-dependent blocking of adsorption by a DIII MAb, 9D12, in the pre- and postadsorption assays.
FIG. 2
FIG. 2
Comparison of percent blocking of adsorption (±95% CI) by representative MAbs for the three distinct E-glycoprotein domains. (A) DI MAb 1B4C-2; (B) DII MAb 4E5; (C) DIII MAb 9D12; (D) DII MAb 1A5D-1; (E) DEN-2 virus polyclonal murine HIAF; (F) DEN-1-specific negative-control MAb 1F1. Panel D illustrates enhancement of virus adsorption.
FIG. 3
FIG. 3
Summary of biological activities and spatial arrangements of the DEN-2 virus E-glycoprotein epitopes listed in Table 1. The biological activities of MAbs elicited by these epitopes were hemagglutination inhibition (HI) and virus neutralization (N). The maximal values for the blocking of virus adsorption are indicated as follows: black, greater than 40%; dark gray, 30 to 40%; light gray, 20 to 30%; white, less than 20% (for A2) or not tested (for A4, C2, C3 and C4); cross-hatched, binding enhancement. Overlapping circles indicate spatially proximal epitopes. Epitope designations: A, DII; B, DIII; C, DI. The HA and N activities of these epitopes were reported previously (19).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Allison S L, Schalich J, Stiasny K, Mandl C W, Heinz F X. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol. 2001;75:4268–4275. - PMC - PubMed
    1. Anderson R, King A D, Innis B L. Correlation of E protein binding with cell susceptibility to dengue 4 virus infection. J Gen Virol. 1992;73:2155–2159. - PubMed
    1. Bhardwaj S, Holbrook M, Shope R E, Barrett A D T, Watowich S J. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol. 2001;75:4002–4007. - PMC - PubMed
    1. Chen Y, Maguire T, Hileman R E, Fromm J R, Esko J D, Linhardt R J, Marks R M. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med. 1997;3:866–871. - PubMed
    1. Colonno R J, Callahan P L, Leippe D M, Rueckert R R, Tomassini J E. Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments. J Virol. 1989;63:36–42. - PMC - PubMed

Publication types

MeSH terms